Skip to content
Search

Latest Stories

‘Cannot ride to the rescue for free,’ pharmacies say as ministers look for their support amid NHS strike

Trade bodies have reiterated the call for more funding in response to the reports that ministers are considering a Pharmacy First scheme amid the NHS strike.

The Sunday Telegraph reported that pharmacies could be drafted in to help the NHS to cope when other healthcare workers take industrial action.


But, a PSNC committee member has warned on Monday that the government suggestions are “categorically impossible” without extra funding.

The Company Chemists' Association (CCA) has echoed the sentiment, saying pharmacy network is on the brink of collapse.

“We welcome plans for a Pharmacy First scheme in England. However, after eight years of funding cuts, the pressures on community pharmacies are simply untenable,” Malcolm Harrison, chief executive of the CCA, said.

“Spiralling inflation, rising costs of medicines and workforce shortages has put the pharmacy network on the brink. The government’s plans must be funded appropriately – pharmacies cannot ride to the rescue for free.”

PSNC chief executive Janet Morrison said the pharmacy has the skills and ambition to help the NHS, but asked the government to offer more funding and support.

“Community pharmacy teams have repeatedly shown that they have the skills, ambition and accessibility to help support patients and the NHS through moments of crisis. But this winter, pharmacies are approaching their own crisis as years of underfunding, efficiency squeezes and workforce problems take their toll,” Morrison said.

“Pharmacy teams are in the same position as their health service colleagues – exhausted, overworked, and struggling to make ends meet.  If [the] government wants pharmacies to step up again, they will need to back this with emergency funding and support.”

PSNC added that they are continuing to stress to the government that already overstretched pharmacy businesses are facing immense and unsustainable financial pressures.

The proposals with ministers reportedly include allowing pharmacist to prescribe for minor conditions, including antibiotics for women with urinary tract infections (UTIs), and giving them powers to diagnose patients with Strep A.

Commenting on the proposals, Fin McCaul, PSNC North-West regional representative and independent community pharmacy contractor, said: “It would make far more sense for us to being doing more on a routine basis because we’ve got the access to patients, the medicines and the testing to make sure they can have the antibiotics and to check they have the UTIs, strep throat, etc. But there’s huge ‘but’ in all of it.

“Just like nurses and doctors, community pharmacies are grossly underfunded. We’re on our knees. To take this on with no increase in core funding, with no new funding, would be categorically impossible.”

Reena Barai, PSNC committee member and independent community pharmacy contractor, added: “A cocktail of issues including medicine supply problems and workforce shortages mean that pharmacists will be unable to push themselves further on current budgets. To add this sort of level of service to what we’re already doing – it would buckle the whole sector.”

More For You

Pharmacist Support calls for birthday donations to meet rising demand for mental health services

More and more pharmacy professionals are reaching out for help, said Danielle Hunt.

Pharmacist Support's birthday appeal: Donate to address growing mental health demand

Pharmacist Support – the independent charity dedicated to the pharmacy profession – is celebrating 184 years of service with the launch of a special birthday donations appeal.

On 15 April, the charity is urging individuals and organisations across the sector to support its campaign to raise vital funds to meet the increasing demand for its mental health and wellbeing services.

Keep ReadingShow less
Prostate cancer: At-home saliva test could save NHS £500 million annually

PRS saliva test can identify prostate cancer that was missed by an MRI scan

Photo credit: gettyimages

Prostate cancer: Spit test better than blood test in spotting men at highest risk

A simple at-home spit test could help detect prostate cancer earlier, saving the NHS around £500 million a year, according to new research published in the New England Journal of Medicine.

Funded by the National Institute for Health and Care Research (NIHR), the study found that the DNA-based saliva test was more accurate than the current prostate-specific antigen (PSA) blood test in identifying men at risk of developing prostate cancer.

Keep ReadingShow less
RPS launches innovative new learning resources for members

With RPS Learn, pharmacists can develop a new skill or improve their understanding of practice or a clinical topic.

Gettyimages

RPS launches new learning resources to boost career development for members

The Royal Pharmaceutical Society (RPS) has launched a new online learning platform designed to support the practice, development and career advancement of its members.

The new platform, called RPS Learn, offers a diverse range of bite-size learning content, available on-demand, catering to all levels — from introductory to advanced and specialist —combining new content with RPS's renowned expertise in education and training to achieve excellence for learners.

Keep ReadingShow less
NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less